Recent research indicates that retatrutide, a dual-action medication, could transform the management of excess weight . Differing from many traditional weight management drugs , retatrutide functions as both a GLP-1 receptor and a GIP agonist, affecting multiple factors involved in cravings regulation and blood sugar control . Preliminary medical